Shima Hadidchi, MD Under the medical supervision of Board-certified and experienced primary care physician, Dr
Self-monitoring before meals and at bedtime helps identify hypoglycemia trends
Managing GI side effects and titration strategies Gastrointestinal adverse events affect 40-70% of treated patients [25], primarily consisting of: Nausea (15-50%) Diarrhea (5-25%) Vomiting (5-10%) Slow titration remains fundamental to mitigating these effects
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide, tirzepatide) slow gastric emptying and commonly cause nausea, vomiting, and diarrhoea, particularly during treatment initiation
Rated 4 out of 5 Kelly (verified owner) Verified review - view original Ive been looking for a product to use where it was easy and hassel free